Overexpression of matrix metalloproteinase-10 and matrix metalloproteinase-3 in human diabetic corneas: A possible mechanism of basement membrane and integrin alterations

American Journal of Pathology

Volumn 158, Issue 2, 2001, Pages 723-734

  Saghizadeh, Mehrnoosh ^a   Brown, Donald J ^a   Castellon, Raquel ^a   Chwa, Marilyn ^a   Huang, Gang H ^a   Ljubimova, Julia Y ^a   Rosenberg, Shari ^a   Spirin, Konstantin S ^a   Stolitenko, Raisa B ^a   Adachi, Wakako ^b   Kinoshita, Shigeru ^b   Murphy, Gillian ^c   Windsor, L Jack ^d   Kenney, M Cristina ^a   Ljubimov, Alexander V ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^c UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^d INDIANA UNIVERSITY SCHOOL OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENTACTIN; INTEGRIN; LAMININ; STROMELYSIN; STROMELYSIN 2;

ARTICLE; BASEMENT MEMBRANE; CONTROLLED STUDY; CORNEA EPITHELIUM; DIABETIC RETINOPATHY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATOCONUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA; ZYMOGRAPHY;

EID: 0035132206     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64015-1     Document Type: Article

References (62)

1. Diabetic retinopathy
2. A review of manifestations of diabetes mellitus in the anterior eye and cornea
3. Dr. P. Siva Reddy oration. Diabetic keratopathy
4. Corneal epithelial fragility in diabetes mellitus
5. Diabetic keratopathy
6. The cornea in diabetes mellitus
7. Evaluation of diabetic retinopathy by fluorophetometry. European concerted action on ocular fluorometry
8. Decreased penetration of anchoring fibrils into the diabetic stroma. A merphometric analysis
9. Reduced number of hemidesmosomes in the corneal epithelium of diabetics with proliferative vitreoretinopathy
10. Altered epithelial-basement membrane interactions in diabetic corneas
11. A modified technique of impression cytology to study the fine structure of corneal epithelium
12. In vivo assessment of corneal endothelial function in diabetes mellitus
13. Advanced Maillard reaction and crosslinking of corneal collagen in diabetes
14. Immunofluorescent characteristics of the diabetic cornea
15. Human corneal epithelial basement membrane and integrin alterations in diabetes and diabetic retinopathy
16. Expression of tenascin-C splice variants in normal and bullous keratopathy human corneas
17. Overview of matrix metalloproteinase expression in cultured human cells
18. Isolation and characterization of human cathepsin V: A major proteinase in corneal epithelium
19. Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas
20. Keratoconus corneas: Increased gelatinolytic activity appears after modification of inhibitots
21. Localization of cathepsin V protein in normal cornea
22. Regulation of MMP gene expression
23. Localization of TIMP-1, TIMP-2, TIMP-3, gelatinase A and gelatinase B in pathological human corneas
24. Matrix metalloproteinases: Biologic activity and clinical implications
25. Overexpression of transforming growth factor-β 1 mRNA is associated with up-regulation of glomerular tenascin and laminin gene expression in nonobese diabetic mice
26. Suppression of basement membrane type IV collagen degradation cell invasion in human melanoma cells expressing an antisense RNA for MMP-1
27. Matrix metalloproteinase inhibitors
28. Matrix metalloproteinases
29. Membrane-type matrix metalloproteinases
30. Antisense inhibition of urokinase: Effect on malignancy in a human osteosarcoma cell line
31. Mechanisms for pro matrix metalloproteinase activation
32. "In vitro" study of basement membrane degradation by the cysteine proteinases, cathepsins B, B-like and L. Digestion of collagen IV, laminin, fibronectin, and release of gelatinase activities from basement membrane fibronectin
33. Cell type-specific regulation of SL-1 and SL-2 genes. Induction of the SL-2 gene but not the SL-1 gene by human keratinocytes in response to cytokines and phorbolesters
34. Human stromelysins 1 and 2
35. Matrix metalloproteinase degradation of elastin, type IV collagen and proteoglycan. A quantitative comparison of the activities of 95 kDa and 72 kDa gelatinases, stromelysins-1 and -2 and punctuated metalloproteinase (PUMP)
36. Stromal fibroblasts synthesize collagenase and stromelysin during long-term tissue remodeling
37. Thyroid hormone regulates stromelysin expression, protease secretion and the morphogenetic potential of normal polarized mammary epithelial cells
38. Stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) expression in developing human bone: Potential roles in skeletal development
39. Regulation of the expression of stromelysin-2 by growth factors in keratinocytes: Implications for normal and impaired wound healing
40. Differential expression of matrix metalloproteinases their physiological inhibitors in acute murine skin wounds
41. Immunolocalization and gene expression of matrilysin during corneal wound healing
42. Matrix metalloproteinase deficiencies affect contact hypersensitivity: Stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response
43. Expression of matrix metalloproteinase genes in transformed rat cell lines of high low metastatic potential
44. Expression of stromelysin and stromelysin-2 in rabbit and human fibroblasts
45. Immunolocalisation studies of six matrix metalloproteinases and their inhibitors, TIMP-1 and TIMP-2, in synovia from patients with osteo- and rheumatoid arthritis
46. Patterns of matrix metalloproteinase TIMP expression in chronic ulcers
47. Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development
48. Circulating levels of matrix metalloproteinases MMP-3 and MMP-1, tissue inhibitor of metalloproteinases 1 (TIMP-1) and MMP-1/TIMP-1 complex in rheumatic disease. Correlation with clinical activity of rheumatoid arthritis versus other surrogate markers
49. Clinical trials of a stromelysin inhibitor. Osteoarthritis, matrix metalloproteinase inhibition, cartilage loss, surrogate markers, and clinical implications
50. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis
51. The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter
52. In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type IV collagen in diabetic nephropathy
53. Growth factors: Importance in wound healing and maintenance of transparency of the cornea
54. IGF-I in diabetic vascular complications
55. Insulin-induced vascular endothelial growth factor expression in retina
56. Regulation of vascular endothelial growth factor-dependent retinal neovascularization by insulin-like growth factor-1 receptor
57. Growth factor and eytokine modulation of trabecular meshwork matrix metalloproteinase and TIMP expression
58. Insulin-like growth factor binding protein-5 expression by human trabecular meshwork
59. MMPs are IGFBP degrading proteinases: Implications for cell proliferation and tissue growth
60. Advanced glycation end products in diabetic corneas
61. Nonenzymatic glycation of type IV collagen and matrix metalloproteinase susceptibility
62. Stromelysin-2 is upregulated during normal would repair is induced by cytokines